Ypsomed And Safety Syringes Inc. Announce Collaboration In The Development Of A Reusable Autoinjector For The UltraSafe Drug Delivery System

BURGDORF, Switzerland & CARLSBAD, Calif.--(BUSINESS WIRE)--April 5, 2005--Ypsomed AG, in collaboration with Safety Syringes Inc., has designed a reusable Autoinjector specifically for use with the UltraSafe(R) Drug Delivery Systems by Safety Syringes Inc. The device will allow flexibility for Pharmaceutical Partners and is intended to ensure that there is no exposure to potential needle stick injuries at any time during or after use and provide additional convenience for self-injecting patients.
Ypsomed has designed an Autoinjector that will accommodate the UltraSafe(R) Passive(TM) Delivery System. "Incorporating safety into a drug delivery system has become very important and the UltraSafe device by Safety Syringes Inc. has proven a preferred product by many of our pharmaceutical clients and by the end-user market," commented Matthew Robin, CEO of Ypsomed Holding AG. "We saw this co-development as an important strategic decision to help offer a full range of solutions to our target client base."